Pulsenmore ES Device, Efficacy and Safety Assessment

NACompletedINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

April 14, 2022

Primary Completion Date

June 9, 2023

Study Completion Date

November 11, 2023

Conditions
Perinatal Care
Interventions
DEVICE

Pulsenmore ES home ultrasound device

Pregnant participants will use Pulsenmore ES device to assess the safety and the efficacy of the device in monitoring fetal parameters

Trial Locations (4)

10029

Mount Sinai Hospital System, New York

90048

Center for Fetal Medicine and Women's Ultrasound, Los Angeles

32601-0294

University of Florida College of Medicine, Gainesville

02115

Brigham and Women's Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

PulseNmore

INDUSTRY

NCT05329077 - Pulsenmore ES Device, Efficacy and Safety Assessment | Biotech Hunter | Biotech Hunter